Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asenapine adjunctive to lithium or valproate in acute manic or mixed episodes (Phase 3)
2004-003927-11Phase 3Terminated
- Sponsor
- Organon & Co.
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bipolar I disorder comparing Asenapine + mood stabilizer with Placebo + mood stabilizer (2 arms). Primary endpoint: Change from baseline to Week 3 in Y-MRS total score (LOCF). Started Jul 2005; status: terminated.
02
Drugs
asenapine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on 2004-003927-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003927-11.